| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |